BEVERLY HILLS, CA--(Marketwired - Sep 28, 2015) - mCig, Inc. (the "Company") (
"MCIG is rapidly expanding its dominance in the CBD Vape market by signing the high end Vape line má to complement its existing product lines," said Paul Rosenberg, CEO. "The MCIG - CBD Globe combination is the fastest road to global distribution and cross border cooperation. Given the huge scale of both the European and US markets, this agreement will provide a unique catalyst for the rapid expansion of both má and MCIG product lines."
má originates from the 10,000 year old Chinese word for Hemp and is globally registered to CBD Globe. má will launch sales in the UK in mid-October and will hit the U.S. market by the end of October 2015.
About mCig, Inc.
mCig, Inc. (
About CBD Globe Distributors Ltd
London based CBD Globe Distributors Ltd (CBDG), creator and owner of the má brand, is a focused and energetic young business. The company's objective is to distribute CBD based products as rapidly and widely as possible, across Europe and overseas using the má brand as our prestigious messenger. Firm believers in CBD and the health benefits and integrity of this remarkable product, CBDG's mission is to expand our range across all categories and to work with the most advanced market leaders in this field. CBDG have selected mCig as the ideal counterparty to assist in this development.
Safe Harbor Statement
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies.
Food And Drug Administration (FDA) Disclosure
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Legal Disclosure
mCig, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US CSA).
Contact Information:
Contact:
Paul Rosenberg
CEO
paul@mcig.org